SCHEMBL29720643

SCHEMBL29720643

Oc1nc(-c2ccncn2)nc2c(-c3ccccn3)csc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP19A1 P11511 3/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TP53 P04637 2/20 0.36
ALDH1A1 P00352 2/20 0.36
PKM P14618 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ALOX15 P16050 1/20 0.36
PDE10A Q9Y233 1/20 0.36
KDM4A O75164 1/20 0.33
KDM4B O94953 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24128157 1.00 KDM4E (0.41) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL20665754 0.91 KDM4E (0.49) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL20665474 0.83 NPC1 (0.44) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL20665609 0.82 KDM4E (0.42) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL18997517 0.82 RAB9A (0.53) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL20665244 0.81 KDM4E (0.42) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL24827580 0.81 PDE10A (0.45) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL20665195 0.80 PRKCI (0.42) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL24128224 0.80 CYP2A6 (0.48) KDM4ETDP1CYP19A1RAB9ANPC1
SCHEMBL29720635 0.80 CYP2A6 (0.48) KDM4ETDP1CYP19A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4168414-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE Shy Therapeutics LLC (US) 2023-04-26 EP disclosed
WO-2021257828-A9 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2022-07-21 WO disclosed